Your browser doesn't support javascript.
loading
Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
Tarantino, Paolo; Gupta, Hersh; Hughes, Melissa E; Files, Janet; Strauss, Sarah; Kirkner, Gregory; Feeney, Anne-Marie; Li, Yvonne; Garrido-Castro, Ana C; Barroso-Sousa, Romualdo; Bychkovsky, Brittany L; DiLascio, Simona; Sholl, Lynette; MacConaill, Laura; Lindeman, Neal; Johnson, Bruce E; Meyerson, Matthew; Jeselsohn, Rinath; Qiu, Xintao; Li, Rong; Long, Henry; Winer, Eric P; Dillon, Deborah; Curigliano, Giuseppe; Cherniack, Andrew D; Tolaney, Sara M; Lin, Nancy U.
Affiliation
  • Tarantino P; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. paolo_tarantino@dfci.harvard.edu.
  • Gupta H; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. paolo_tarantino@dfci.harvard.edu.
  • Hughes ME; Harvard Medical School, Boston, MA, USA. paolo_tarantino@dfci.harvard.edu.
  • Files J; Department of Oncology and Hematology-Oncology, University of Milano, Milano, Italy. paolo_tarantino@dfci.harvard.edu.
  • Strauss S; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kirkner G; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Feeney AM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Li Y; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Garrido-Castro AC; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Barroso-Sousa R; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bychkovsky BL; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • DiLascio S; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sholl L; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • MacConaill L; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.
  • Lindeman N; Harvard Medical School, Boston, MA, USA.
  • Johnson BE; Dasa Institute for Education and Research (IEPD), Brasilia, Brazil.
  • Meyerson M; Dasa Oncology/Hospital Brasilia, Brasilia, Brazil.
  • Jeselsohn R; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.
  • Qiu X; Harvard Medical School, Boston, MA, USA.
  • Li R; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Long H; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Winer EP; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Dillon D; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Curigliano G; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Cherniack AD; Department of Pathology, Weill Cornell Medicine, New York, NY, USA.
  • Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Lin NU; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nat Commun ; 14(1): 8321, 2023 Dec 14.
Article in En | MEDLINE | ID: mdl-38097580
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2023 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2023 Document type: Article Affiliation country: United States